When Medications Give Way to Surgery: New Evidence Emerges on Diabetes Treatment

A new study published in the journal Annals of Internal Medicine has shown that surgical treatment for patients with type 2 diabetes (T2D) is more effective than standard medication and lifestyle-based approaches, regardless of patients’ levels of social vulnerability.

The study included 258 adults diagnosed with T2D from four academic centers in the United States who participated in four trials comparing metabolic bariatric surgery with medical therapy and lifestyle interventions.

Researchers assessed the impact of social vulnerability—measured using the Area Deprivation Index (ADI)—on treatment outcomes.

Patients were divided into groups with high and low levels of social deprivation. The results demonstrated that surgical intervention outperformed medical therapy on two key indicators—glycated hemoglobin (HbA1c) levels and weight loss—in both ADI groups, indicating that social status does not alter the effectiveness of surgery.

The difference in HbA1c levels between the surgical and medical approaches was −1.29% among patients with high ADI and −0.95% among those with low ADI, reflecting a greater reduction in those who underwent surgery. A similar trend was observed for weight loss: the difference was −10.6% in the high-ADI group and −13.3% in the low-ADI group.

Glycated hemoglobin (HbA1c) is an important marker of diabetes control, with lower levels associated with a reduced risk of serious complications such as cardiovascular disease, kidney damage, and nervous system disorders. In this context, bariatric or metabolic surgery not only promotes weight loss but also positively affects glucose metabolism and insulin sensitivity.

Social deprivation is traditionally considered a factor that complicates achieving good disease control due to limited access to healthy food, medical care, and educational resources. However, the study’s findings indicate that the effectiveness of surgical treatment remains consistent regardless of social conditions, which may have implications for developing treatment guidelines for T2D across different population groups.

The authors note that these results support efforts to tailor diabetes treatment strategies based on patients’ clinical needs rather than solely on their social status, although further research is needed to clarify long-term outcomes and optimize patient selection for surgical intervention.